We confirmed that the silkworm carboxypeptidase inhibitor inhibited the expression of c-Myc through the MAPK/ERK pathway initiated by EGF/EGFR, thereby affecting the related cyclins and inhibiting the proliferation of gastric cancer cells. Here, MYC is linked to gastric cancer.